Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 57,836 | 52,475 | 45,239 | 50,129 | 47,712 |
| Cost of Goods | 10,581 | 7,498 | 9,383 | 8,684 | 7,947 |
| Gross Profit | 47,255 | 44,977 | 35,856 | 41,445 | 39,765 |
| Operating Expenses | 73,638 | 66,916 | 57,030 | 47,764 | 45,163 |
| Operating Income | -25,802 | -21,441 | -20,791 | -5,635 | -4,451 |
| Interest Expense | 3,533 | 706 | 604 | 1,518 | 1,537 |
| Other Income | 6,993 | 3,915 | 4,195 | 3,642 | 3,024 |
| Pre-tax Income | -22,342 | -18,232 | -17,200 | -3,511 | -2,964 |
| Income Tax | 470 | 153 | 214 | 525 | 307 |
| Net Income Continuous | -22,812 | -18,385 | -17,414 | -4,036 | -3,271 |
| Net Income | $-21,723 | $-18,385 | $-17,414 | $-4,036 | $-16,941 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-22,357 | $-18,120 | $-18,081 | $-2,551 | $-1,558 |